@Datamonitor_SY

Views expressed are my own.

Joined March 2017
  • Tweets68
  • Following84
  • Followers54
New Drug Application submitted for investigational #RA treatment in Japan: bit.ly/2AQGaQD.

Gilead Sciences Submits New Drug Application for Filgotinib for the Treatment of Adults With...

Gilead Sciences Submits New Drug Application for Filgotinib for the Treatment of Adults With Rheumatoid Arthritis in Japan

gilead.com
7
1
15
Big thanks to Mandy Jackson @ScripMandy and Stephanie Yip @Datamonitor_SY for joining this month's podcast!
Michael Ramirez, Ph.D.@pharma_MR_PhD20 Mar 2019
Check out the COMPLETELY FREE Informa Pharma Intelligence Podcast! -Bristol-Myers Squibb $BMY and Celgene $CELG merger (1:37) -Selinexor PDUFA for multiple myeloma delayed $KPTI (16:18) -Approval of Spravato $JNJ (28:47) soundcloud.com/dmhcap/031920…
3
1
7
Bipolar disorder market sales across the US, #Japan, and five major EU markets by country 2014-23. @Datamonitor_SY @datamonitor_ch Learn More: bit.ly/2IHgDPl #bipolar #breakthestigma #stopthestigma #mentalhealthawarenessmonth #pharmaintelligence @BipolarAdvantag
2
3
Stephanie Yip retweeted
zach@zbiotech10 Apr 2018
$ABBV $NBIX - elagolix PDUFA pushed out 90d due to request for additional info re liver function tests provided by $ABBV
1
5
3
Roche kicking off two new gantenerumab studies in its GRADUATE #Alzheimers program: clinicaltrials.gov/ct2/resul…
4
2
Roche's RG7716 raises the bar beyond anti-VEGF therapy alone in P2 DME study, threatening Eylea (and potentially brolucizumab). roche.com/investors/updates/…
5
9
Stephanie Yip retweeted
The Lancet
@TheLancet25 Jan 2018
Lennox-Gastaut syndrome, a form of treatment-resistant #epilepsy: pharmaceutical formulation of cannabidiol may help to reduce #seizures hubs.ly/H09NJtb0
1
10
1
15
Stephanie Yip retweeted
The Lancet
@TheLancet22 Dec 2017
Editorial—Artificial intelligence in #health care: within touching distance #AI hubs.ly/H09wLL30
2
59
8
61
Online now! Diagnosis of #MultipleSclerosis: 2017 revisions of the McDonald criteria. Free w/ reg thelancet.com/journals/laneu…
33
5
32
New target and a new disease for Boehringer Ingelheim as it acquires rights to potassium channel modulators from Autifony in schizophrenia boehringer-ingelheim.com/pre…
4
Two large trials demonstrate efficacy of anti-CGRP antibodies for prevention of migraine nejm.org/doi/full/10.1056/NE… nejm.org/doi/full/10.1056/NE…
2
8
6
Reducing levels of the RNA binding protein TIA1 protects against tau-mediated neurodegeneration in vivo nature.com/articles/s41593-0…
6
8
$SAGE P3 data looking promising, pricing remains a factor to be decided. A few takeaways: Rapid reduction is a novelty within the depression market. P2/P3 data discrepancy is a minor let down. Read further on our DM website. service.datamonitorhealthcar…
1
Magnetic resonance neurography demonstrates peripheral nerve involvement in multiple sclerosis onlinelibrary.wiley.com/reso…
7
2
4
Also new today: Human models of migraine — short-term pain for long-term gain go.nature.com/2z332u3 #newfromnrneurology
2
32
4
51
Stephanie Yip retweeted
BBC Health News
@bbchealth6 Oct 2017
Father loses IVF damages claim bbc.in/2yt7eGF
3
1
3
Stephanie Yip retweeted
Bipolar UK
@BipolarUK30 Mar 2017
Bipolar affects over 1 million people in the UK. Learn more about bipolar with our info and support bit.ly/29aVJVn #WorldBipolarDay
115
8
85
Load more